<DOC>
	<DOCNO>NCT00442234</DOCNO>
	<brief_summary>To investigate PK coagulate fibrinolytic parameter profile ( PD ) approve dose ( 13,750 - 27,500 IU/kg ) patient acute pulmonary embolism accompany hemodynamic instability .</brief_summary>
	<brief_title>Post-marketing Study Monteplase ( `` Cleactor '' ) Patients With Acute Pulmonary Embolism</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<criteria>1 ) Patients consent study participation submit write informed consent free patient legally authorize representative . 2 ) Patients age 20 year 75 year old time obtain informed consent . 3 ) Patients acute pulmonary embolism within 5 day onset . 4 ) Patients acute pulmonary embolism hemodynamic instability fulfill follow 4 item : 1 . Confirmed thrombus , embolus , disorder pulmonary circulation detect pulmonary angiography compute tomography . 2 . Confirmed follow right ventricular overload echocardiography : ) Dilation right ventricular cavity hypokinesis ventricular wall ii ) Floating thrombi pulmonary artery right heart iii ) Paradoxical motion interventricular septum iv ) Disparity tricuspid regurgitation pressure v ) Loss inrespiratory change inferior vena cava diameter vi ) Enlargement pulmonary artery 3 . Mean pulmonary arterial pressure ( PAP ) 20 mmHg 4 . PaO2 65 mmHg ( confirm blood gas analysis ) 1 . Patients concurrent hemorrhage ( e.g. , gastrointestinal bleeding , urinary tract bleeding , retroperitoneal bleeding , intracranial bleeding , hemoptysis ) . 2 . Patients underwent intracranial spinal operation injury within 2 month prior study treatment . 3 . Patients intracranial tumor , arteriovenous malformation , aneurysm 4 . Patients hemorrhagic diathesis ( e.g. , vascular purpura , thrombocytopenia , hemophilia ) 5 . Patients hypertension systolic blood pressure &gt; =180 mmHg diastolic pressure &gt; = 110 mmHg . 6 . Patients history cerebrovascular disorder ( e.g. , cerebral infarction , intracerebral hemorrhage ) . 7 . Patients severe hepatic disorder ( e.g. , cirrhosis , severe hepatitis ) severe renal disorder ( e.g. , renal failure ) . 8 . Patients receive thrombolytic drug ( tPA urokinase ) within 7 day prior study treatment . 9 . Patients pulmonary cardiac arrest ( CPA ) . 10 . Patients history hypersensitivity monteplase protein preparation . 11 . Pregnant woman , woman suspect pregnant , woman desire become pregnant period obtain informed consent final observation , lactate woman . 12 . Patients judge ineligible study entry investigator subinvestigator .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Acute</keyword>
	<keyword>pulmonary</keyword>
	<keyword>embolism</keyword>
	<keyword>accompany</keyword>
	<keyword>hemodynamic</keyword>
	<keyword>instability</keyword>
</DOC>